Peter Fernandes
Président chez The Pulmonary Vascular Research Institute
Fortune : 1 906 $ au 30/04/2024
Postes actifs de Peter Fernandes
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
The Pulmonary Vascular Research Institute
 The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK. | Président | - | - |
Historique de carrière de Peter Fernandes
Anciens postes connus de Peter Fernandes
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 05/05/2023 | 15/11/2023 |
| Directeur Général | 11/11/2021 | 15/11/2023 | |
| Directeur Financier/CFO | 05/05/2023 | 15/11/2023 | |
| Conseiller Juridique Général | 20/05/2015 | 15/11/2023 | |
| IKARIA, INC. | Conseiller Juridique Général | 01/10/2012 | 01/05/2015 |
| OPTINOSE, INC. | Conseiller Juridique Général | 01/10/2010 | 01/09/2012 |
| Novartis Pharmaceuticals AG | Corporate Officer/Principal | 01/11/2007 | 01/10/2010 |
ALTANA Pharma US, Inc.
 ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ. | Conseiller Juridique Général | 01/02/2005 | 01/10/2007 |
Formation de Peter Fernandes
| The Grant Government Medical College | Graduate Degree |
| Principal K. M. Kundnani College of Pharmacy | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Inde | 3 |
| Royaume-Uni | 2 |
Opérationnelle
| General Counsel | 4 |
| Comptroller/Controller/Auditor | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| OPTINOSE, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
ALTANA Pharma US, Inc.
ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ. | Health Technology |
| Novartis Pharmaceuticals AG | |
The Pulmonary Vascular Research Institute
The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK. | Commercial Services |
- Bourse
- Insiders
- Peter Fernandes
- Expérience
